Whereas the research on the effector phase of CD8+ T cell response against malaria has been quite extensive (22–25), a rather limited number of studies attempted to dissect the issue of liver stage-specific CD8+ T cell priming in the infected host. The gene discussed is CD8A; the disease is malaria.